Aesthetic medicine products. Walgreens Boots Alliance 4Q2021: sales up 12.8 percent yoy after 4Q results exceed expectations

Derma filler

THE WHAT? Walgreens Boots Alliance has reported its results for the final quarter and fiscal year ending August 31, 2021. The drug store operator’s results exceeded expectations across business segments, with sales from continuing operations up 12.8 percent yoy to US$34.3 billion in the fourth quarter, bringing sales growth for the year to 8.6 percent versus 2020’s figures.

THE DETAILS Net earnings from continuing operations hit US$2 billion for fiscal 2021, versus US$180 million in the year-ago period. Adjusted net earnings were up 12.8 percent yoy.

Fat dissolving

While sales were up across WBA’s US and International divisions, the latter delivered the most impressive uptick with the international segment reporting an increase of 61.8 percent in the fourth quarter comparted to the same period a year ago, attributed to the ongoing recovery in the UK market, and stronger demand for pharmacy services, most notably COVID-19 tests.

THE WHY? Chief Executive Officer Roz Brewer said, “Our fourth quarter and fiscal year results exceeded expectations, driven by strong performance in our core business. Comparable US pharmacy and retail sales both saw robust growth and recovery continued in our UK business as COVID-19 restrictions eased in the quarter. I remain extremely proud of our team members’ unwavering commitment to meeting the needs of our patients, customers and communities. The role of the pharmacist and local pharmacy is now more vital than ever.”

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

  Aesthetic medicine products. Clarins expands live video shopping via long-term agreement with Bambuser

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.